| Drug Name: | Cardizem |
| Manufacturer: | Biovail Pharmaceuticals, Inc. |
| Other Info: | Prescribing Information as of August 2001® Cardizem is a registered trademark ofBiovail Laboratories IncorporatedManufactured by: Aventis Pharmaceuticals Inc.Kansas City, MO, 64137, USADistributed by: Biovail Pharmaceuticals, Inc.Bridgewater, NJ, 08807, USA50070835 |
| Clinical Trials: | |
CARDIZEM CD is indicated for the treatment of hypertension.
It may be used alone or in combination with other antihypertensive medications.CARDIZEM CD is indicated for the management of chronic stable angina and angina due to coronary artery spasm.1.
Cardiac Conduction.
CARDIZEM prolongs AV node refractory periods without significantly prolonging sinus node recovery time, except in patients with sick sinus syndrome.
This effect may rarely result in abnormally slow heart rates (particularly in patients with sick sinus syndrome) or second- or third-degree AV block (13 of 3290 patients or 0.40%).
Concomitant use of diltiazem with beta-blockers or digitalis may result in additive effects on cardiac conduction.
A patient with Prinzmetal's angina developed periods of asystole (2 to 5 seconds) after a single dose of 60 mg of diltiazem.
(See ADVERSE REACTIONS section.)